Insect Cell Expression Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Insect Cell Expression Market: By Product Type (Reagents, Expression Vectors, Competent Cells, Instruments, Services), By Application (Therapeutic Applications, Industrial Applications, Research Applications), and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category: Tag:

Report

Description

The insect cell expression market is estimated to be valued at USD 292.4 Million in 2021 and is poised to grow at a significant CAGR of 12.4% over 2022-2028. Insect cells offer high levels of protein expression with posttranslational modification approaching that of mammalian cells, ease of scale-up, and simplified cell growth that can be readily adapted to high-density suspension culture for large-scale expression. Based on product type the global insect cell expression market is segmented into reagents, expression vectors, competent cells, instruments, and services. Regents segment anticipated to hold largest market share and the growth of this segment is attributed to the rising incidences of increasing research activities in the field of protein expression and the large-scale production of antibodies and vaccines. Furthermore, based on the application the global insect cell expression market is segmented into therapeutic applications, industrial applications, and research applications. The therapeutic application segment accounted to grow at a significant CAGR over the forecast years owing to a surge in the prevalence of chronic diseases coupled with the increase in the R&D for the novel therapeutics by the market players across the globe. Increasing in demand for protein biologics, growth in the geriatric population, rise in the life science and biopharmaceutical industries, increasing research activities on recombinant-based protein expression, and availability of funding for protein-based research are anticipated to propel the growth of market over the forecast years.

Recent Market Developments:

In 2020, Thermo Fisher’s launched ExpiSf Expression System, which Offers 3X Higher Protein Yields in a Shorter Time. The ExpiSf Expression System is a complete chemically defined baculovirus-insect cell protein expression system that delivers superior yields.

In May 2019, Oxford expression Technologies Ltd launched BaculaQuant All in one titration of recombinant Baculoviruses, features includes Titre accuracy comparable to plaque assay method and Compatible with any AcMNPV-based baculovirus system containing gp64 virus gene.

 

Insect Cell Expression Market

MARKET SUMMARY
-
12.4% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 12.4%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North America

Insect Cell Expression Market

  • The insect cell expression market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The insect cell expression market is segmented based on product type, application, and geography.
Key Players
  • LifeSensors
  • ProteoGenix
  • Promega Corporation
  • New England Biolabs
  • Bio-RadLaboratories Inc.
Insect Cell Expression Market

Dynamics

The demand for protein therapeutics has gradually increased in the past few years and is expected to grow at a prominent growth rate over the forecast timeframe owing to the rapid growth in the geriatric population most prone to chronic diseases across the globe. Moreover, the surge in R&D activities for the novel therapeutics by market players owing to the surge in prevalence of chronic diseases and rare diseases also increase the revenue of the market over the forecast years. Fundraising from public and private sectors for the development of novel therapeutics and the development of advanced technologies also propel the growth of the market over the forecast years.


North-America Got Significant Share

Insect Cell Expression Market

North America accounted to have the highest share in the global insect cell expression market and the market is expected to grow at a significant CAGR over the forecast years. The growth in this region can be attributed to growing the presence of a huge number of market players focus on the development of novel therapeutics for the treatment of rare diseases and other chronic diseases. Moreover, The Europe region accounted to have the second-highest growth rate in the global insect cell expression market and is projected to grow at significant CAGR over 2022 - 2028due to the high incidence of chronic diseases, increasing public and private investments, and an increase in life sciences research.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The insect cell expression market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The insect cell expression market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The insect cell expression market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The insect cell expression market report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The insect cell expression market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Insect Cell Expression Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • LifeSensors (US)
  • ProteoGenix (US)
  • Lonza (Switzerland)
  • Peak Proteins Ltd. (UK)
  • Merck KGaA (Germany)
  • Takara Bio, Inc. (Japan)
  • Promega Corporation (US)
  • New England Biolabs (US)
  • Bio-RadLaboratoriesInc.(US)
  • Synthetic Genomics Inc. (US)
  • Agilent Technologies Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • GenScript Biotech Corporation (US)
  • Oxford Expression Technologies Ltd. (UK)

Description

The insect cell expression market is estimated to be valued at USD 292.4 Million in 2021 and is poised to grow at a significant CAGR of 12.4% over 2022-2028. Insect cells offer high levels of protein expression with posttranslational modification approaching that of mammalian cells, ease of scale-up, and simplified cell growth that can be readily adapted to high-density suspension culture for large-scale expression. Based on product type the global insect cell expression market is segmented into reagents, expression vectors, competent cells, instruments, and services. Regents segment anticipated to hold largest market share and the growth of this segment is attributed to the rising incidences of increasing research activities in the field of protein expression and the large-scale production of antibodies and vaccines. Furthermore, based on the application the global insect cell expression market is segmented into therapeutic applications, industrial applications, and research applications. The therapeutic application segment accounted to grow at a significant CAGR over the forecast years owing to a surge in the prevalence of chronic diseases coupled with the increase in the R&D for the novel therapeutics by the market players across the globe. Increasing in demand for protein biologics, growth in the geriatric population, rise in the life science and biopharmaceutical industries, increasing research activities on recombinant-based protein expression, and availability of funding for protein-based research are anticipated to propel the growth of market over the forecast years.

Recent Market Developments:

In 2020, Thermo Fisher’s launched ExpiSf Expression System, which Offers 3X Higher Protein Yields in a Shorter Time. The ExpiSf Expression System is a complete chemically defined baculovirus-insect cell protein expression system that delivers superior yields.

In May 2019, Oxford expression Technologies Ltd launched BaculaQuant All in one titration of recombinant Baculoviruses, features includes Titre accuracy comparable to plaque assay method and Compatible with any AcMNPV-based baculovirus system containing gp64 virus gene.

 

Reviews

There are no reviews yet.

Be the first to review “Insect Cell Expression Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX